These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26474281)

  • 1. Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors.
    Liu YQ; Wang XL; Cheng X; Lu YZ; Wang GZ; Li XC; Zhang J; Wen ZS; Huang ZL; Gao QL; Yang LN; Cheng YX; Tao SC; Liu J; Zhou GB
    Oncotarget; 2015 Oct; 6(33):34953-67. PubMed ID: 26474281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
    Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
    Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis.
    Xing S; Nong F; Wang Y; Huang D; Qin J; Chen YF; He DH; Wu PE; Huang H; Zhan R; Xu H; Liu YQ
    Pharmacol Res; 2022 Feb; 176():106059. PubMed ID: 34998973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
    He DH; Chen YF; Zhou YL; Zhang SB; Hong M; Yu X; Wei SF; Fan XZ; Li SY; Wang Q; Lu Y; Liu YQ
    Cancer Sci; 2021 Aug; 112(8):3218-3232. PubMed ID: 34080260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
    Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
    Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel [1,2,4]Triazolo[1,5-
    Hu K; Luo Y; Miao P; Zhao L; Zhao B; Shi XJ; Liu HM
    J Med Chem; 2024 Sep; 67(18):16435-16454. PubMed ID: 39285177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
    Chandra Dantu S; Nathubhai Kachariya N; Kumar A
    Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma.
    Liu Y; Chen XQ; Liang HX; Zhang FX; Zhang B; Jin J; Chen YL; Cheng YX; Zhou GB
    PLoS One; 2011; 6(7):e21930. PubMed ID: 21755010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual drug design: Skp1-Skp2 inhibition targets cancer stem cells.
    Pascal LE; Wang Z
    Asian J Androl; 2013 Nov; 15(6):717-8. PubMed ID: 24077600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening for inhibitors of the Cks1-Skp2 interaction.
    Huang KS; Vassilev LT
    Methods Enzymol; 2005; 399():717-28. PubMed ID: 16338391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
    Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
    Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
    Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.